These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30010117)

  • 1. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
    Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
    J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.
    Merino-Zamorano C; Fernández-de Retana S; Montañola A; Batlle A; Saint-Pol J; Mysiorek C; Gosselet F; Montaner J; Hernández-Guillamon M
    J Alzheimers Dis; 2016 May; 53(2):677-91. PubMed ID: 27232214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.
    Saint-Pol J; Candela P; Boucau MC; Fenart L; Gosselet F
    Brain Res; 2013 Jun; 1517():1-15. PubMed ID: 23603412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drugs modulate ATP-Binding cassette transporter-mediated transport of amyloid beta
    Shubbar MH; Penny JI
    Eur J Pharmacol; 2020 May; 874():173009. PubMed ID: 32061744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro.
    Chan SL; Kim WS; Kwok JB; Hill AF; Cappai R; Rye KA; Garner B
    J Neurochem; 2008 Jul; 106(2):793-804. PubMed ID: 18429932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
    Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.
    Saint-Pol J; Vandenhaute E; Boucau MC; Candela P; Dehouck L; Cecchelli R; Dehouck MP; Fenart L; Gosselet F
    J Alzheimers Dis; 2012; 30(3):489-503. PubMed ID: 22433669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier.
    Akanuma S; Ohtsuki S; Doi Y; Tachikawa M; Ito S; Hori S; Asashima T; Hashimoto T; Yamada K; Ueda K; Iwatsubo T; Terasaki T
    Neurochem Int; 2008 May; 52(6):956-61. PubMed ID: 18201804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of endogenous AβPP in blood-brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis.
    Schweinzer C; Kober A; Lang I; Etschmaier K; Scholler M; Kresse A; Sattler W; Panzenboeck U
    J Alzheimers Dis; 2011; 27(2):341-60. PubMed ID: 21811018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
    Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.
    Hanafy AS; Lamprecht A; Dietrich D
    Fluids Barriers CNS; 2023 Nov; 20(1):85. PubMed ID: 37993886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease.
    Behl T; Kaur I; Sehgal A; Kumar A; Uddin MS; Bungau S
    Mol Neurobiol; 2021 Apr; 58(4):1564-1582. PubMed ID: 33215389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
    Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.